Reme-D: Funding, Investors & Team (Sep 2026)
Reme-D is a cutting-edge technology company that has patented technology, which is revolutionizing healthcare in areas with limited resources by providing cost-effective and efficient disease testing systems. This ensures that everyone has equal access to essential medical diagnostics.
Reme-D has raised $1.9M across 3 funding rounds on record, the most recent a Seed of $1.4M announced in Jul 2026.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Reme-D Company Profile and Key Stats
Latest funding round on record: Jul 2026.
Reme-D Funding Rounds
1 of 3 rounds was announced without a disclosed amount and is excluded from the total.
Reme-D announced an undisclosed round in Jun 2024; the amount was not disclosed.
1.8 years later, a Seed of $500k was announced in Apr 2026.
3 months later, a Seed of $1.4M was announced in Jul 2026.
Reme-D Investors
9 investors are recorded in total; the 5 named above are those the record identifies.
Reme-D Founders and Leadership Team
Contact details for the Reme-D team: 1 of 1 has an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →Reme-D Funding Compared to Other Biotechnology Startups
Reme-D's latest round of $1.4M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Reme-D in Biotechnology and New York
Companies Similar to Reme-D
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Reme-D Funding FAQs
What does Reme-D do?
Reme-D is a cutting-edge technology company that has patented technology, which is revolutionizing healthcare in areas with limited resources by providing cost-effective and efficient disease testing systems. This ensures that everyone has equal access to essential medical diagnostics.
How much funding has Reme-D raised?
Reme-D has raised $1.9M across 3 rounds on record. The most recent is a Seed of $1.4M announced in Jul 2026.
When did Reme-D last raise funding?
Reme-D's most recent funding round on record is a Seed of $1.4M, announced in Jul 2026.
Who has invested in Reme-D?
Investors on record for Reme-D include Anara Impact Capital, Wharton School of the University of Pennsylvania, Mohammed Bin Rashid Innovation Fund (MBRIF), A15, Global Innovation Fund. FundedIQ records 9 investors in total.
Who founded Reme-D?
FundedIQ lists Salma Tammam (Founder) at Reme-D.
Where is Reme-D headquartered?
Reme-D is based in New York, United States.
How many employees does Reme-D have?
Reme-D is in the 11-50 employee band.
When was Reme-D founded?
Reme-D was founded in 2022.
How does Reme-D's funding compare to other Biotechnology startups?
Reme-D's latest round of $1.4M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Reme-D Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Reme-D is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.